✦ LIBER ✦

ASPECCT: panitumumab versus cetuximab for colorectal cancer – Authors' reply

✍ Scribed by Price, Timothy J; Peeters, Marc; Ruff, Paul; Murugappan, Swaminathan; Sidhu, Roger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ASPECCT: panitumumab versus cetuximab fo

✍ Hawkes, Eliza A; Wong, Rachel 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 50 KB

ASPECCT: panitumumab versus cetuximab fo

✍ Sunakawa, Yu; Ichikawa, Wataru; Sasaki, Yasutsuna 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 49 KB

Cetuximab in metastatic colorectal cance

✍ Gunnar Folprecht; Claus-Henning Köhne 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 42 KB

Panitumumab versus cetuximab in patients

✍ Price, Timothy J; Peeters, Marc; Kim, Tae Won; Li, Jin; Cascinu, Stefano; Ruff, 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 592 KB

Anti-EGFR Monoclonal Antibodies for Trea

✍ You, Benoit; Chen, Eric X. 📂 Article 📅 2012 🏛 Sage Publications 🌐 English ⚖ 404 KB

Chemotherapy for colorectal cancer – Aut

✍ Michel Ducreux; David Malka; Jean-Pierre Pignon 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 37 KB